Literature DB >> 15275768

Sensitization to bradykinin B1 and B2 receptor activation in UV-B irradiated human skin.

Harald Eisenbarth1, Roman Rukwied, Marlen Petersen, Martin Schmelz.   

Abstract

Bradykinin B1 and B2 receptors contribute to nociceptor sensitization under inflammatory conditions. Here, we examined the vascular inflammatory responses and nociceptive effects resulting from activation of B1 and B2 receptors in healthy and UV-B irradiated skin in human volunteers. The B1 receptor agonist des-Arg(10)-Kallidin (10(-6)-10(-3)M) and the B2 receptor agonist bradykinin (10(-9)-10(-4)M) were administered by dermal microdialysis to the ventral thigh. UV-B irradiation was performed 24 h prior to the experiment with the threefold minimum erythemal dose. Pain sensation perceived during the stimulation with the bradykinin receptor agonists was estimated on a numeric scale. Local and axon reflex-induced vasodilations were recorded by laser Doppler imaging. For protein extravasation, total protein content in the dialysate was assessed as a measure of increased endothelial permeability. In normal skin, both B1 and B2 receptor activation dose-dependently evoked pain, vasodilatation and protein extravasation. In UV-B irradiated skin, pain sensation and axon reflex vasodilatation were enhanced by both B1 and B2 agonists, whereas local vasodilatation was increased only following B1 receptor activation. The UV-B irradiation did not enhance B1 and B2 receptor-induced protein extravasation indicating a differential sensitization of the neuronal, but not the vascular response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15275768     DOI: 10.1016/j.pain.2004.03.031

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  8 in total

Review 1.  [Mechanisms in the development of pain. Key issue in the periphery].

Authors:  C Konrad; M Schmelz
Journal:  Internist (Berl)       Date:  2005-10       Impact factor: 0.743

2.  Functional evidence of des-Arg10-kallidin enzymatic inactivating pathway in isolated human umbilical vein.

Authors:  Wanda Nowak; Ezequiel Dario Goldschmidt; Alejandra Georgina Falcioni; Mariana Ines Pugliese; Andrea Emilse Errasti; Facundo German Pelorosso; Federico Manuel Daray; Juan Ezequiel Gago; Rodolfo Pedro Rothlin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-20       Impact factor: 3.000

3.  Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor.

Authors:  Alyson Fox; Satbir Kaur; Bifang Li; Moh Panesar; Uma Saha; Clare Davis; Ilaria Dragoni; Sian Colley; Tim Ritchie; Stuart Bevan; Gillian Burgess; Peter McIntyre
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

Review 4.  Translating nociceptive processing into human pain models.

Authors:  Martin Schmelz
Journal:  Exp Brain Res       Date:  2009-04-29       Impact factor: 1.972

5.  Local gene expression changes after UV-irradiation of human skin.

Authors:  Benjamin Weinkauf; Roman Rukwied; Hans Quiding; Leif Dahllund; Patrick Johansson; Martin Schmelz
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

Review 6.  Arthritis and pain. Future targets to control osteoarthritis pain.

Authors:  Andy Dray; Simon J Read
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

7.  Characterisation and mechanisms of bradykinin-evoked pain in man using iontophoresis.

Authors:  Kathryn J Paterson; Laura Zambreanu; David L H Bennett; Stephen B McMahon
Journal:  Pain       Date:  2013-01-11       Impact factor: 6.961

8.  The ultraviolet B inflammation model: Postinflammatory hyperpigmentation and validation of a reduced UVB exposure paradigm for inducing hyperalgesia in healthy subjects.

Authors:  Pieter S Siebenga; Guido van Amerongen; Erica S Klaassen; Marieke L de Kam; Robert Rissmann; Geert Jan Groeneveld
Journal:  Eur J Pain       Date:  2019-02-01       Impact factor: 3.931

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.